1758954650 unnamed file.jpg

Trump’s 100% tariffs on branded drugs: Indian generics spared but pose risks for pharma sector – Explained

US President Donald Trump‘s announcement of a 100% tariff on imported “branded and patented pharmaceutical products” has rattled the global pharma industry, though Indian generic drug makers are largely expected to remain unaffected for now.Trump, in a post on Truth Social on Thursday, stated: “Starting October 1st, 2025, we will be imposing a 100% Tariff…

Read More
1758918528 unnamed file.jpg

Not a med emergency: Generic pharma cos spared from harm

NEW DELHI/HYDERABAD: India’s generic companies are likely to continue in business-as-usual mode as US President Donald Trump’s 100% levy on pharmaceuticals is targeted at branded and patented medicines, but it may also prompt some of them to rethink their playbook.Industry experts told TOI that the country’s largest drugmaker Sun Pharma could face headwinds as its…

Read More